Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Insmed Incorporated
IM8NCurrent price
67.5 EUR
+2.99 EUR (+4.65%)
Last closed
62.5 EUR
Company
www.insmed.com
ISIN
US4576693075
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
11 339 040 698 EUR
Yield for 12 month
+196.05 %
1Y
3Y
5Y
10Y
15Y
IM8N
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
48.07 EURP/E ratio
–Dividend Yield
–Current Year
+283 352 971 EUR
Last Year
+227 788 650 EUR
Current Quarter
+83 871 024 EUR
Last Quarter
+70 093 672 EUR
Current Year
+222 475 457 EUR
Last Year
+176 610 057 EUR
Current Quarter
+64 408 193 EUR
Last Quarter
+53 886 715 EUR
Key Figures IM8N
1 year
3 years
5 years
10 years
EBITDA
-701 811 096 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.05 %
PEG Ratio
–
Return On Equity TTM
-890.75 %
Wall Street Target Price
48.07 EUR
Revenue TTM
346 291 149 EUR
Book Value
2.73 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
18.2 %
Dividend Yield
–
Gross Profit TTM
192 080 823 EUR
Earnings per share
-5.15 EUR
Diluted Eps TTM
-5.15 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-252.01 %
Dividend Analytics IM8N
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IM8N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
03.03.2011
Dividend Date
–
Stock Valuation IM8N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
34.2742
Price Sales TTM
32.7442
Enterprise Value EBITDA
-5.7089
Price Book MRQ
24.772
Financials IM8N
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IM8N
For 52 weeks
20.19 EUR
72.7 EUR
50 Day MA
66.91 EUR
Shares Short Prior Month
–
200 Day MA
47.88 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart